Hormone Therapy for Breast Cancer: 454 Real Stories

454 stories match breast cancer and hormone therapy. 383 of them mention surgery.

Cherie, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Cherie's Survivor Story

Patient Info: Cherie, Female, 60s | Stage II

Cherie completed treatment and described herself as being in remission. She remained concerned about recurrence but shifted her focus toward family and retirement.

Our Cancer Stories
OutcomeCancer-Free / Remission
Laura, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Laura's Survivor Story

Patient Info: Laura

Laura said everything was free of malignant cells and was rebuilding her life and career after treatment.

Our Cancer Stories
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

Breast Cancer Recurrence in the Liver Mimicking Cirrhosis

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: Original cancer: HER2-negative and PR-positive. Liver recurrence: ER-positive.

Metastatic Site: liver

The breast cancer recurred in the liver after 14 years, produced pseudocirrhosis and portal-hypertension complications, and she died from hepatorenal syndrome five weeks after presentation.

PubMed Central
OutcomeIn Memory
Janet, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Janet's Survivor Story

Patient Info: Janet Klein, Female | Stage IV

Metastatic Site: Bone: left iliac bone

Janet’s Stage 1 breast cancer later recurred and metastasized to the left iliac bone, but she had no sign of cancer from January 2010 onward while continuing palbociclib plus letrozole.

AACR
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Breast Cancer Recurrence in the Parotid Gland Eight Years Later

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: Primary breast tumor: ER-positive and HER2-positive. Parotid metastasis: ER-positive, PR-negative, and HER2-positive.

Metastatic Site: left parotid gland

The isolated parotid metastasis was completely resected, one-month PET-CT showed no significant abnormality, and endocrine therapy continued with exemestane.

PubMed Central
OutcomeCare Ongoing
MB
Breast Cancer

Metastatic Breast Cancer Presenting With Severe Pulmonary Hypertension

Patient Info: Anonymized, Female, Under 40 | Stage IV

Biomarkers: ER-positive; PR-positive.

Metastatic Site: bone; bone marrow

At seven months, she was doing well with a marked response on PET imaging, normalized right-heart pressures, and ongoing systemic treatment with palbociclib.

PubMed Central
OutcomeResponding Well
Margaret, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Breast Cancer Survivor Story: Chemo, Double Mastectomy, Radiation, Reconstruction

Patient Info: Margaret, Female | Stage II

Biomarkers: Oncotype DX score reported around 16-18; genetic testing negative; specific inherited gene not named

As of June 2019, Margaret was in remission after Stage II IDC treated with double mastectomy, AC/Taxol chemotherapy, radiation, and reconstruction.

The Patient Story
OutcomeCancer-Free / NED
A patient, who was diagnosed with Invasive Ductal CarcinomaBreast Cancer

Breast Cancer Arising in Ectopic Tissue in the Armpit

Patient Info: Anonymized, Female, 40s

Biomarkers: ER positive; PR positive; HER2 negative

A 43-year-old woman’s presumed axillary cyst proved to be hormone-receptor-positive breast cancer arising in ectopic breast tissue.

PubMed Central
OutcomeNot reported
Eliza, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Eliza's Patient Story

Patient Info: Eliza | Stage II

Eliza continued to live with fear of recurrence after lumpectomy, radiation therapy, and hormone therapy caused fatigue, inflamed skin, and joint and bone pain.

Our Cancer Stories
OutcomeNot reported
Ana, who was diagnosed with Stage II Breast CancerBreast Cancer

Ana's Stage 2 Breast Cancer Treatment and Recovery Story

Patient Info: Ana, Female, 40s | Stage II

Years after diagnosis, Ana had completed chemotherapy, mastectomy, radiation and reconstruction and was continuing hormone therapy with anastrozole. She described herself as optimistic and grateful.

Our Cancer Stories
OutcomeCare Ongoing / Survivorship
Aura, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Aura's Patient Story

Patient Info: Aura, Female, 40s | Stage I

Aura completed mastectomy, lymphadenectomy, hysterectomy, and chemotherapy for Stage I breast cancer and remained on hormone therapy, with ongoing concerns but no documented recurrence or progression.

Our Cancer Stories
OutcomeCare Ongoing
Carole, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Carole's Survivor Story

Patient Info: Carole, Female, 60s | Stage III

Carole was diagnosed with Stage III breast cancer in 2019 and was declared cancer-free at the end of 2023 after a treatment plan involving surgery, chemotherapy, radiation therapy, and hormonal therapy.

Our Cancer Stories
OutcomeCancer-Free / NED
Cath, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II HR-Positive Breast Cancer: Cath's Survivor Story

Patient Info: Cath, Female, 60s | Stage II

Biomarkers: ER-positive; PR-positive; HER2-negative

Cath was declared cancer-free in June 2024 after Stage II luminal A ER-positive/PR-positive/HER2-negative breast cancer treated with surgery, radiation, and hormone therapy, though she continued to manage long-term side effects and recurrence fear.

Our Cancer Stories
OutcomeCancer-Free / NED
Magnolia, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Magnolia's Survivor Story

Patient Info: Magnolia | Stage IV

Magnolia was declared cancer-free in March 2022 and described herself as remaining in remission while continuing hormone therapy.

Our Cancer Stories
OutcomeCancer-Free / NED
Emma, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Emma's Patient Story

Patient Info: Emma, Female, 40s | Stage II

As of 2019, Emma had completed active treatment for Stage II breast cancer after mastectomy, lymphadenectomy, chemotherapy, and hormone therapy, and she remained on hormone therapy.

Our Cancer Stories
OutcomeCare Ongoing
A patient, who was diagnosed with Invasive Lobular CarcinomaBreast Cancer

Splenectomy Reduced Transfusion Needs in Metastatic Lobular Breast Cancer

Patient Info: Anonymized, Female, 40s | Stage Metastatic/Advanced

Biomarkers: ER positive; PR positive; HER2 negative

Metastatic Site: skin|bone|bone marrow|spleen

She remained independent through her last oncology visit 18 months after splenectomy and died 1 month later.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Inflammatory Breast CancerBreast Cancer

Metastatic Breast Cancer Causing Severe Shoulder and Arm Pain

Patient Info: Anonymized, Female, 50s | Stage Metastatic/Advanced

Metastatic Site: bone

Progressive nodal disease caused disabling brachial-plexus pain. She died about 3 months after placement of the intrathecal pain catheter.

PubMed Central
OutcomeIn Memory
Ken, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Ken's Survivor Story

Patient Info: Ken Gremling, Male, 70+

Ken's mastectomy removed all of the cancer, and his clinicians expected a full recovery while he continued tamoxifen.

Cleveland Clinic
OutcomeCancer-Free / NED
Jane, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Jane's Survivor Story

Patient Info: Jane Gremling, Female, 60s

Jane's mastectomy removed all of the cancer, and her clinicians expected a full recovery while she continued tamoxifen and prepared for reconstruction.

Cleveland Clinic
OutcomeCancer-Free / NED
A patient, who was diagnosed with Breast AdenocarcinomaBreast Cancer

Breast Cancer Recurring 18 Years After Mastectomy

Patient Info: Anonymized, Female, 70+ | Stage Metastatic/Advanced

Metastatic Site: sternum|lungs|pleura|chest wall

She died during respiratory decline caused by both metastatic breast cancer in the lungs and a separate primary lung cancer.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Invasive Lobular CarcinomaBreast Cancer

Lobular Breast Cancer Spreading to an Eye Muscle

Patient Info: Anonymized, Female, 40s | Stage Metastatic/Advanced

Biomarkers: Hormone receptor-positive; HER2-negative; E-cadherin-negative; CK7-positive

Metastatic Site: bones|left superior oblique eye muscle

The eye-muscle metastasis entered complete local remission, while bone disease was stable after 6 months of weekly paclitaxel and denosumab.

PubMed Central
OutcomeStable Disease
A patient, who was diagnosed with Invasive Ductal CarcinomaBreast Cancer

Recurrent Breast Cancer Initially Mistaken for Organising Pneumonia

Patient Info: Anonymized, Female, 60s | Stage Metastatic/Advanced

Biomarkers: ER-positive and GATA3-positive atypical pleural-fluid cells

Metastatic Site: lungs

After 12 months of first-line hormone therapy for metastatic recurrence, she had significant clinical and radiological improvement and remained on treatment.

PubMed Central
OutcomeResponding Well